From: Chemotherapy near the end of life: a retrospective single-centre analysis of patients’ charts
Author | Näppä | Earle | Kao | Braga | Barbera | Our results |
---|---|---|---|---|---|---|
Country | Sweden | USA Canada | Australia | Portugal | Canada | Switzerland |
No of patients | 1200 | 215′848 | 747 | 639 | 21323 | 119 |
Period analysed (years) | 1 | 10 | 2 | 1 | 1 | 2 |
Median age (years) | 65 | ≥ 65 | 67 | 61 | 72 | 75 |
Sex f/m (%) | 44/56 | NA | 44/56 | 61/39 | 47/53 | 40/60 |
Chemotherapy in last 4 weeks (%) | 7.3 | NA | 9.8 | 18.8 | NA | 11.7 |
4.7 new | 6.7 new | |||||
Chemotherapy in last 2 weeks (%) | NA | 9.7-11.6 | 4.3 | 10.7 | 4.2 | 7.6 |
1.7 new |